van Rijckevorsel Echenne B, Dulac O, Parayre-Chanez MJ, et al. 1991. Treatment of infantile spasms with intravenous gamma-globulins. Brain Dev, 13:313–9. Eder HG, Feichtinger M, Pieper T, et al. 2006. Gamma Knife radiosurgery for callosotomy in children with drug-resistant epilepsy. Childs Nerv Syst, 22:1012–7. EMEA report 2007. URL: http://www.emea.europa.eu/humandocs/PDFs/ EPAR/diacomit/H-664-en6.pdf. Engel J. 2001. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy. Report of the ILAE Task Force on Classiﬁcation and Terminology. Epilepsia, 42:796–803. Eriksson AS, Nergardh A, Hoppu K. 1998. The efﬁcacy of lamotrig- ine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia, 39:495–501. Espinosa Zacarias J, Gutierrez Moctezuma J, Villegas Pena H, et al. 2002. Intravenous treatment with immunoglobulins in epileptic syndromes which are difﬁcult to control. Rev Neurol, 34:816–9. Farrell K. 1986. Benzodiazepines in the treatment of children with epilepsy. Epilepsia, 27(S1):S45–S52. Farrell K, Connolly MB, Munn R, et al. 1997. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr Neurol, 16:201–5. Farrell K. 2002. Drug therapy in Lennox-Gastaut syndrome. Adv Exp Med Biol, 77:486–97. Farwell JR, Anderson GD, Kerr BM, et al. 1993. Stiripentol in atypical absence seizures in children: an open trial. Epilepsia, 34:305–11. Feasby T, Banwell B, Benstead T, et al. 2007. Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions. Transfus Med Rev, 21(2,S1):S57–S107. Feichtinger M, Schröttner O, Eder H, et al. 2006. Efﬁcacy and safety of radiosurgical callosotomy: a retrospective study. Epilepsia, 47:1184–91. Felbamate Study Group in Lennox-Gastaut Syndrome. 1993. Efﬁcacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med, 328:29–33. Ferrie CD, Maisey M, Cox T, et al. 1996. Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Arch Dis Child, 75:102–7. Feucht M, Brantner-Inthaler S. 1994. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study. Epilepsia, 35:993–8. Fois A, Vascotto M. 1990. use of intravenous immunoglobulins in drug-resistant epilepsy. Childs Nerv Syst, 6:400–5. Freeman JM, Vining EPG, Pillas DJ, et al. 1998. The efﬁcacy of the ketogenic diet – 1998: a prospective evaluation of intervention in 150 children. Pediatrics, 102:1358–63. Freeman JM, Vining PG.1999. Seizures decrease rapidly after fasting. Preliminary studies of the ketogenic diet. Arch Pediatr Adolesc Med, 153:946–9. Freese A, Kaplitt MG, O’Connor WM, et al. 1997. Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy. Epilepsia, 38:759–66. French J, A.M. Kanner AM, Bautista J, et al. 2004. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 62:1261–73. Frost M, Gates J, Helmers SL et al. 2001. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia, 42:1148–52. Garland H, Sumner D. 1964. Sulthiame in treatment of epilepsy. Br Med J, 1:474–6. Gastaut H, Roger J, Soulayrol R, et al. 1966. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “Petit mal variant”) or Lennox syndrome. Epilepsia, 7:139–79. 1016 Gay PE, Mecham GF, Coskey JS, et al. 1995. Behavioral effects of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Psychol Rep, 77:1208–10. Genton P, Guerrini R, Dravet C. 2000. The Lennox-Gastaut syn- drome. In: Meinardi H. ed. Handbook of Clinical Neurology, Vol. 73 (29): The Epilepsies, Part II. Amsterdam: Elsevier: Publisher. p. 211–22. Gibbs FA, Gibbs EL, Lennox WG. 1939. Inﬂuence of blood sugar level on wave and spike formation in petit mal epilepsy. Arch Neurol Psychiatry, 41:1111. Glauser TA, Sachdeo RC, Ritter FJ, et al. 1997. Topiramate as adjunctive therapy in Lennox-Gastaut syndrome. Epilepsia, 38:207. Glauser TA. 1998. Topiramate use in pediatric patients. Can J Neurol Sci, 39:874–7. Glauser TA, Levisohn PM, Ritter F, et al. 2000. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group. Epilepsia, 41(S1):S86–S90. Glauser TA, Pellock JM. 2002. Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neurol, 17:87–96. Glauser TA. 2004. Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia, 45(S5):23–6. Glauser T, Kluger G, Sachedo R, et al. 2005. Efﬁcacy and safety of rufinamide adjunctive therapy in patients with Lennox-Gastaut syndrome (LGS): a multicenter, randomized, double-blind, placebo-controlled, parallel trial. Neurology, 64:1826 (Abstract). Goldsmith IL, Zupanc ML, Buchhalter JR. 2000. Long-term seizure oucome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in deﬁning the cryptogenic group. Epilepsia, 41:395–9. Gross-Tsur V, Shalev RS, Kazir E, et al. 1993. Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand, 88:204–9. Guerreiro MM, Manreza ML, Scotoni AE, et al. 1999. A pilot study of topiramate in childen with Lennox-Gastaut syndrome. Arq Neuropsiquiatr, 57:167–75. Gur RC, Sussman NM, Alavi A, et al. 1982. Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome) Neurology, 32:1191. Hakimian S, Cheng-Hakimian A, Anderson GD, et al. 2007. Ruﬁnamide: a new anti-epileptic medication. Exp Opin Pharmacother, 8:1931–40. Han SH, Chung SY. 2000. Melatonin attenuates trimethyltin-induced hippocampal neurodegeneration Neurobiology of Aging, 21(S1):226. Hancock E, Cross H. 2003. Treatment of Lennox-Gastaut syndrome. Cochrane Database of Systematic Reviews, Issue 3. Art. No: CD003277. DOI: 10.1002/14651858.CD003277. Hartman AL, Vining EP. 2007. Clinical aspects of the ketogenic diet. Epilepsia, 48:31–42. Heiskala H. 1997. Community-based study of Lennox-Gastaut syndrome. Epilepsia, 38:526–31. Hemingway C, Freeman JM, Pillas DJ, et al. 2001. The ketogenic diet: a 3 to 6 year follow-up of 150 children enrolled prospectively. Pediatrics, 108:898–905. Henderson CB, Filloux FM, Alder SC, et al. 2006. Efﬁcacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol, 21:193–8. Holowich J, Thurston DL. 1958. A clinical evaluation of acetazolamide (Diamox) in the treatment of epilepsy in children. J Pediatr, 53:160–71. Hornig GW, Murphy JV, Shallert G, et al. 1997. Left vagus nerve stimulation in children with refractory epilepsy: an update. South Med J, 90:484–8. Hosain S, Nikalov B, Harden C, et al. 2000. Vagus nerve stimula- tion treatment for Lennox-Gastaut syndrome. J Child Neurol, 15:509–12. Hosain SA, Green NS, Solomon GE, et al. 2003. Nitrazepam for the treatment of Lennox-Gastaut syndrome. Pediatr Neurol, 28:16–9. Neuropsychiatric Disease and Treatment 2008:4(6)